HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peritoneal sclerosis: role of plasticizers in stimulating interleukin-1 production.

Abstract
The role of plasticizers (PLS) in inducing water flow inhibition and peritoneal sclerosis has been demonstrated in both in vivo and in vitro studies. Interleukin-1 (IL-1) has been shown to be a regulator of fibroblast proliferation as well as collagenase production. The aim of this study was to evaluate the role of PLS in stimulating mononuclear cell IL-1 secretion. Two cultures containing 10(3) cells/mL were obtained from 14 healthy subjects. One was used as the control, and the other was mixed with diethylhexylphthalate (DEHP) to reach a final concentration of 2.8 x 10(-3) M. After 4 hours the samples were centrifuged, and the supernatants were tested by radioimmunoassay for IL-1 alpha and IL-1 beta. The results showed a significant increase in both IL-1 alpha and IL-1 beta production in DEHP-stimulated cells in comparison to the controls: 42.6 +/- 15.4 versus 29.3 +/- 10 ng/L (p < 0.015) for IL-1 alpha, and 153.6 +/- 55 versus 113.6 +/- 32 ng/L (p < 0.03) for IL-1 beta In conclusion, PLS added to mononuclear cells were able to induce IL-1 secretion. This mechanism could be responsible, at least in part, for the development of peritoneal sclerosis. Thus the employment of plasticizer-free bags should be elective in peritoneal dialysis.
AuthorsA Fracasso, L Calo, S Landini, P Morachiello, F Righetto, F Scanferla, P Toffoletto, R Genchi, D Roncali, S Cantaro
JournalPeritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (Perit Dial Int) Vol. 13 Suppl 2 Pg. S517-9 ( 1993) ISSN: 0896-8608 [Print] United States
PMID8399653 (Publication Type: Journal Article)
Chemical References
  • Interleukin-1
  • Diethylhexyl Phthalate
Topics
  • Adult
  • Diethylhexyl Phthalate (adverse effects, pharmacology)
  • Female
  • Humans
  • In Vitro Techniques
  • Interleukin-1 (biosynthesis)
  • Male
  • Middle Aged
  • Monocytes (metabolism)
  • Peritoneal Dialysis, Continuous Ambulatory (adverse effects, instrumentation)
  • Peritoneum (pathology)
  • Sclerosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: